Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Date

14 November 2026

Millions still face barriers to essential medicines despite company efforts

In an article for The Capital Times, Ronald Ahabwe reports on the Access to Medicine Foundation’s 2026 Access to Medicine Index and the continuing difficulty millions of people in low- and middle-income countries face in obtaining essential medicines, despite pharmaceutical companies’ growing efforts to improve access.
Read the full article

SHARE

Reports and publications

The Index finds that access plans now cover 69% of medicines in late-stage development, more than three times the share in 2018. Ahabwe sets this growth in planning against persistent barriers to affordability, availability and distribution. Marking 20 years of the Index, the 2026 assessment also puts greater emphasis on implementation and measurable results, distinguishing company commitments from progress. 

Cancer shows how uneven the plans remain: strategies have been developed for 74% of assessed cancer products in lower-middle-income countries, compared with 19% in low-income countries. For diabetes, access to newer treatments remains limited in many low-income markets, while insulin is still expensive or difficult for many patients to obtain. 

The article also reports that six companies run inclusive business programmes across multiple countries, collectively covering all 113 countries assessed. However, limited product- and country-level information makes their actual impact difficult to measure. Claudia Martínez, the Foundation’s Director of Research, says positive developments in medicine approvals, research and licensing agreements remain concentrated among a small number of companies and disease areas. She calls on more manufacturers to adopt successful approaches. 

In the media

Read more of our global media coverage
Media

Access to medicines: innovations not reaching those in need

14 November 2026
Media

Novartis and GSK retain top positions in the 2026 Access to Medicine Index

12 November 2026

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved